Panagora Asset Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Panagora Asset Management’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-48,470	Closed	-$1.01M	–	2485
2016 Q3	$1.01M	Buy	+48,470	New	+$558K	﹤0.01%	1188
2016 Q1	–	Sell	-2,409	Closed	-$44K	–	2388
2015 Q4	$44K	Buy	+2,409	New	+$33.1K	﹤0.01%	2013

Panagora Asset Management's VTAE Position: Q4 2016 in Review

Panagora Asset Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 48,470 shares — an estimated $1.01M sold.

Panagora Asset Management first reported a position in VTAE in Q4 2015 and held it in 2 quarters. The position peaked at $1.01M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Panagora Asset Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Panagora Asset Management sold 48,470 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $1.01M.
Panagora Asset Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2015 and held it in 2 quarters.
Panagora Asset Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $1.01M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Panagora Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.